Skip to main content

Table 4 Comparison between COVID-19 patients who survived vs. those who died

From: DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome

Variable

COVID-19, died N = 24a

COVID-19, survived N = 76a

p-valub

Age

58 (52, 63)

47 (41, 56)

 < 0.001

Gender (male)

24 (100%)

70 (92%)

0.023

BMI (kg/m2)

25.7 (24.5, 29.7)

27.5 (25.4, 32.1)

0.072

Ethnicity

 Middle East

1 (4.1%)

2 (2.6%)

0.14

 North Africa

0 (0%)

1 (1.3%)

 Northeast Africa

2 (8.2%)

4 (5.2%)

 South Asia

18 (75%)

63 (82.8%)

 Southeast Asia

2 (8.2%)

5 (6.5%)

 Western Asia

1 (4.1%)

1 (1.3%)

 Duration of MV (days)

25 (19, 41)

8 (5, 18)

 < 0.001

 ICU LoS (days)

26 (20, 48)

15 (11, 29)

 < 0.001

 ECMO

7 (29%)

10 (13%)

0.001

 Nosocomial infections

22 (92%)

42 (55.2%)

 < 0.001

 Convalescent plasma therapy

9 (37.5%)

25 (32.8%)

0.4

Diabetes status

 No diabetes

15 (62.5%)

41 (53.9%)

0.14

 Pre-diabetes

1 (4.1%)

4 (5.2%)

 Diabetes

8 (33.4%)

31 (40.7%)

 Hypertension

11 (46%)

31 (40.7%)

0.5

 Coronary artery disease

1 (4.1%)

4 (6.2%)

0.8

 Chronic kidney failure

3 (12.5%)

8 (10.5%)

0.3

 Chronic heart failure

1 (4.1%)

3 (3.9%)

0.9

  1. Data are represented as numbers (%) per each category for categorical variables and as median (Interquartile range, IQR) for continuous variables
  2. ECMO extracorporeal membrane oxygenation, LoS length of stay, MV mechanical ventilation
  3. aMedian (IQR); n (%)
  4. bWilcoxon rank-sum test; Fisher's exact test; Pearson's Chi-squared test
  5. P-values were calculated with Fisher exact test or Wilcoxon rank-sum test